1. Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309: 883–887.
2. Bast RC Jr, Klug TL, Schaetzl E, Lavin P, Niloff JM, Greber TF, Zurawski VR Jr, Knapp RC. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. Am J Obstet Gynecol 1984; 149: 553–559.
3. Klug RL, Bast RC Jr, Niloff JM, Knapp RC, Zurawski VR Jr. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Research 1984; 44: 1048–1053.
4. Takahashi K, Fukuda S, Yoshino K, Shibukawa T, Murao F, Kitao M. Diagnostic usefulness of serum CA 125 in patients with ovarian cancer. Shimane J Med Sci 1985; 9: 43–48.
5. Takahashi K, Yoshino K, Shibukawa T, Kitao M. The normal levels of an antigenic determinant CA 125 in healthy non-pregnant Japanese. The World of Obstetrics and Gynecology 1985; 37: 717–719.